SCHEMBL7208800

SCHEMBL7208800

CCc1noc([C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](OC(C)=O)[C@@H]2O)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 8/20 0.49
ADORA2A P29274 3/20 0.48
ADORA1 P30542 3/20 0.48
ADORA2B P29275 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA9 Q16790 1/20 0.47
NT5E P21589 9/20 0.45
PDE2A O00408 1/20 0.45
ADRA1A P35348 1/20 0.45
PDE4D Q08499 1/20 0.45
PDE3A Q14432 1/20 0.45
CD99 P14209 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7208805 0.95 ADORA3 (0.51) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL7206682 0.90 ADORA3 (0.52) ADORA3ADORA2AADORA1ADORA2BALDH1A1
Acetic Acid SCHEMBL7208795 0.88 ADORA3 (0.57) ADORA3ADORA2AADORA1ADORA2BCA1
SCHEMBL7206694 0.85 ADORA3 (0.54) ADORA3ADORA2AADORA1ADORA2BALDH1A1
Acetic Acid SCHEMBL7206675 0.78 ADORA3 (0.59) ADORA3ADORA2AADORA1ADORA2BCA1
SCHEMBL7209134 0.77 ADORA3 (0.47) ADORA3ADORA2AADORA1ADORA2BCA1
SCHEMBL10026390 0.76 ALDH1A1 (0.59) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL19837866 0.75 ALDH1A1 (0.66) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL19157590 0.74 P2RY11 (0.60) ADORA3ADORA2AADORA1ADORA2BCA1
SCHEMBL10026389 0.74 P2RY11 (0.60) ADORA3ADORA2AADORA1ADORA2BCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610665-B1 Treatment of inflammatory diseases, asthma or chronic obstructive pulmonary disease SMITHKLINE BEECHAM CORPORATION 2003-08-26 US disclosed
EP-1056759-B1 2-(PURIN-9-YL) -TETRAHYDROFURAN-3, 4-DIOL DERIVATIVES GLAXO GROUP LTD (GB) 2002-09-04 EP disclosed
EP-1056759-A1 2-(PURIN-9-YL) -TETRAHYDROFURAN-3, 4-DIOL DERIVATIVES GLAXO GROUP LIMITED (GB) 2000-12-06 EP disclosed
WO-1999041267-A1 2-(PURIN-9-YL) -TETRAHYDROFURAN-3, 4-DIOL DERIVATIVES GLAXO GROUP LIMITED (GB) 1999-08-19 WO disclosed